12
Participants
Start Date
June 23, 2020
Primary Completion Date
December 11, 2020
Study Completion Date
December 31, 2020
NM-002
NM-002 is a fusion protein, of which the pharmacological active portion is the glucagon-like peptide-1 (GLP-1) analog domain with the same amino acid sequence as the active pharmaceutical ingredient (exenatide)
Research Facility One, Los Angeles
Lead Sponsor
9 Meters Biopharma, Inc.
INDUSTRY